Cell and Gene Therapy Bioassay Services Market
完整報告名稱與涵蓋範圍
Cell and Gene Therapy Bioassay Services Market Size, Share & Trends Analysis Report By Type of Therapy (Cell Therapy, Gene Therapy), By Therapeutic Area, By Scale of Operation (Discovery, Preclinical, Clinical), By Region, And Segment Forecasts, 2025-2034
報告摘要
Across the 2025 to 2034 projection horizon, the worldwide Cell and Gene Therapy Bioassay Services Market is set to register a CAGR of 25.0%.
Cell and Gene Therapy Bioassay Services encompasses challenges.
Several factors contribute to this trajectory, including heightened requirement next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region set to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cell and Gene Therapy Bioassay Services Market Snapshot
Chapter 4. Global Cell and Gene Therapy Bioassay Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 2: By Therapeutic Area Estimates & Trend Analysis
5.1. By Therapeutic Area & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapeutic Area:
5.2.1. Oncological
5.2.2. Infectious
5.2.3. Autoimmune
5.2.4. Rare / Genetic
5.2.5. Cardiovascular
5.2.6. Metabolic
5.2.7. Blood
5.2.8. Neurological
5.2.9. Ophthalmic Disorders
5.2.10. Other Therapeutic Areas
Chapter 6. Market Segmentation 3: By Therapy Estimates & Trend Analysis
6.1. By Therapy & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapy:
6.2.1. Cell Therapy
6.2.2. Gene Therapy
Chapter 7. Market Segmentation 4: By Scale of Operations Estimates & Trend Analysis
7.1. By Scale of Operations & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Scale of Operations:
7.2.1. Discovery
7.2.2. Preclinical
7.2.3. Clinical
Chapter 8. Cell and Gene Therapy Bioassay Services Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
8.1.2. North America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts By Therapy, 2021-2034
8.1.3. North America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2021-2034
8.1.4. North America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapeutic Area, 2021-2034
8.2.2. Europe Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapy, 2021-2034
8.2.3. Europe Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2021-2034
8.2.4. Europe Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapeutic Area, 2021-2034
8.3.2. Asia Pacific Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapy, 2021-2034
8.3.3. Asia Pacific Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2021-2034
8.3.4. Asia Pacific Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapeutic Area, 2021-2034
8.4.2. Latin America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapy, 2021-2034
8.4.3. Latin America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2021-2034
8.4.4. Latin America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapeutic Area, 2021-2034
8.5.2. Middle East & Africa Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapy, 2021-2034
8.5.3. Middle East & Africa Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2021-2034
8.5.4. Middle East & Africa Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. AnaBioTec
9.2.2. CCRM
9.2.3. Nexelis
9.2.4. Pacific BioLabs
9.2.5. PPD Laboratories
9.2.6. Intertek Pharmaceutical Services
9.2.7. Lonza
9.2.8. Porton Bio
9.2.9. WuXi Advanced Therapies
9.2.10. Avomeen
9.2.11. Charles River Laboratories
9.2.12. Absorption Systems
9.2.13. BioAgilytix Labs
9.2.14. Catalent, Inc
9.2.15. MilliporeSigma
9.2.16. Svar Life Science AB
Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們